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Abstract
Background: SNAP-25 is a synaptic protein known to be involved in exocytosis of synaptic
vesicles in neurons and of large dense-core vesicles in neuroendocrine cells. Its role in exocytosis
has been studied in SNAP-25 knockout mice, in lysed synaptosomes lacking functional SNAP-25
and in cells after treatment with botulinum toxins A or E that specifically cleave SNAP-25. These
studies have shown that SNAP-25 appears to be required for most but not all evoked secretion. In
order to further study the role of SNAP-25 in catecholamine secretion from PC12 cells we have
used the recently developed technique of RNA interference to generate PC12 cell lines with
virtually undetectable levels of SNAP-25. RNA interference is the sequence-specific silencing or
knockdown of gene expression triggered by the introduction of double-stranded RNA into a cell.
RNA interference can be elicited in mammalian cells in a number of ways, one of which is by the
expression of small hairpin RNAs from a transfected plasmid. Selection of stably transfected cell
lines expressing a small hairpin RNA allows one-time characterization of the degree and specificity
of gene silencing and affords a continuing source of well-characterized knockdown cells for
experimentation.
Results: A PC12 cell line stably transfected with a plasmid expressing an shRNA targeting SNAP-
25 has been established. This SNAP-25 knockdown cell line has barely detectable levels of SNAP-
25, but normal levels of other synaptic proteins. Catecholamine secretion elicited by depolarization
of the SNAP-25 knockdown cells was reduced to 37% of control.
Conclusion: Knockdown of SNAP-25 in PC12 cells reduces but does not eliminate evoked
secretion of catecholamines. Transient expression of human SNAP-25 in the knockdown cells
rescues the deficit in catecholamine secretion.
Background
SNAP-25 along with syntaxin and synaptobrevin are the
SNARE proteins known to be involved in exocytosis of
synaptic vesicles in neurons and of large dense-core vesi-
cles in neuroendocrine cells [1,2]. The role of SNAP-25 in
exocytosis has been studied in a variety of different exper-
imental preparations [3-7]. These studies have shown that
SNAP-25 appears to be required for most but not all
evoked secretion. In order to further study the role of
SNAP-25 in catecholamine secretion from PC12 cells we
have used the recently developed technique of RNA inter-
ference to generate PC12 cell lines with barely detectable
levels of SNAP-25.
RNA interference is the sequence-specific "silencing" or
"knockdown" of gene expression triggered by the intro-
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duction of double-stranded RNA into a cell [8-10]. In
mammalian cells this double-stranded RNA must be short
(<30 bp), but may be either a simple RNA duplex with
two unpaired nucleotides on the 3'-ends (small interfer-
ing RNA or siRNA; [11]) or a small hairpin RNA (shRNA)
[12-16]. The siRNA or shRNA may be chemically synthe-
sized, transcribed in vitro, produced by enzymatic cleav-
age of long double-stranded RNA, or expressed in situ
from a plasmid or viral vector. For cells, such as PC12
cells, where only a modest transfection efficiency can be
achieved, the use of viral vectors or the establishment of
cell lines stably transfected with a vector expressing an
shRNA are the best approaches to RNA interference. Pro-
duction of stably transfected cell lines can be the most
time-consuming option, but allows one-time characteri-
zation of the degree and specificity of gene silencing and
affords a continuing source of well-characterized knock-
down cells for experimentation.
Plasmid-based expression of shRNA-SNAP-25 Figure 1
Plasmid-based expression of shRNA-SNAP-25. A) Plasmid map of pG418-shRNA, a plasmid designed to express shR-
NAs from the mouse U6 promoter. B) The two 56-base deoxyoligonucleotides used in the construction of pG418-shRNA-
SNAP-25 are shown as they would be paired after annealing. The labels above and below the oligonucleotides indicate the 
source or the function of the nucleotides in the indicated regions. C) The predicted stem-loop structure of shRNA-SNAP-25 
expressed from pG418-shRNA-SNAP-25.
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Specific silencing of SNAP-25 by RNA interference Figure 2
Specific silencing of SNAP-25 by RNA interference. A) Immunoblots were done to assess the levels of SNAP-25, SNAP-
23, synaptotagmin I, syntaxin 1A, tyrosine hydroxylase and β-actin in wild type PC12 cells, SNAP-25 knockdown cells and in 
control transfected cells (PC12 cells stably transfected with pG418-shRNA lacking an shRNA insert). Equal amounts of protein 
were loaded per lane. B) The SNAP-25 phenotype is maintained for at least 10 weeks in culture in both the parent PC12 cell 
line and the SNAP-25 knockdown cell line. C) Human and zebrafish SNAP-25 mRNAs are resistant to RNA interference. The 
specificity of the SNAP-25 shRNA was demonstrated by transiently transfecting SNAP-25 knockdown cells with plasmids 
designed to express SNAP-25 cDNA of rat, human, or zebrafish origin. The 19 nucleotide region of rat SNAP-25 mRNA which 
is targeted by the SNAP-25 shRNA differs from human SNAP-25 RNA at only 2 positions and from zebrafish SNAP-25 mRNA 
in 4 positions. The immunoblot shows that expression of rat SNAP-25 was silenced in the SNAP-25 knockdown cells, but 
human and zebrafish SNAP-25 were expressed. All three SNAP-25 cDNAs appeared to be expressed in the control trans-
fected cells in that there was more SNAP-25 in the control transfected cells than in untransfected PC12 cells. The immunoblot 
was stripped and reprobed for β-actin to demonstrate approximately equal amounts of protein in each sample. D) SNAP-25 
mRNA is reduced in SNAP-25 knockdown cells. RT-PCR was carried out with RNA isolated from wild type PC12 cells, SNAP-
25 knockdown cells and in control transfected cells. SNAP-25 mRNA was easily detected in wild type and control transfected 
PC12 cells, but no SNAP-25 mRNA was detected in the SNAP-25 knockdown cells in this PCR experiments. However, if more 
of the reverse-transcription product was used for the PCR or if more cycles were done in the PCR reaction, some SNAP-25 
mRNA was detectable in the SNAP-25 knockdown cells.
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In the work presented here we have established and char-
acterized a PC12 cell line stably transfected with a plasmid
that expresses an shRNA specific for rat SNAP-25. These
cells have <5% of normal levels of SNAP-25, but normal
levels of all other synaptic proteins investigated. As
expected, the SNAP-25 knockdown cells exhibited dimin-
ished catecholamine secretion in response to depolarizing
stimuli.
Results
A plasmid designed to express an shRNA targeting rat
SNAP-25 (Figure 1) was successfully constructed and
transfected into 1.25 × 106 PC12 cells. A total of 47 colo-
nies survived selection with G418, 11 colonies were iso-
lated and grown up, and 6 of the colonies tested positive
by PCR for incorporation of pG418shRNA-SNAP-25. The
stable transfection efficiency was approximately 1 cell in
50,000. All six of the stably transfected cell lines had sig-
nificantly reduced levels of SNAP-25, but the extent of
knockdown varied among the cell lines (data not shown).
The cell line with the least (5 ± 4 % of normal SNAP-25 as
determined by densitometry of 8 immunoblots) amount
of SNAP-25 was chosen for further characterization and
will be referred to as SNAP-25 knockdown cells (Figure
2A). The stability of the SNAP-25 knockdown phenotype
was confirmed by immunoblots showing that knock-
down of SNAP-25 persisted for at least 10 weekly passages
of the cells (Figure 2B). In order to prevent phenotypic
drift (which has been a problem with PC12 cells) the cul-
tures were used for only 8–10 weeks before reverting to
frozen stocks from an early passage. A similar number of
colonies were obtained after transfection with the vector
pG418shRNA lacking an shRNA insert, and one was cho-
sen as the control stably transfected cell line. The control
transfected cell line had levels of SNAP-25 comparable to
the parent PC12 cells (Figure 2A). Although the SNAP-25
shRNA expressed from pG418shRNA-SNAP-25 was effec-
tive in silencing SNAP-25, it did not conform fully to the
most stringent guidelines for design of effective shRNAs
[17-20].
The knockdown of SNAP-25 was specific in that levels of
several other proteins known to be involved in catecho-
lamine synthesis and secretion were unchanged (Figure
2A) Specifically levels of SNAP-23, synaptotagmin I, syn-
taxin 1A, tyrosine hydroxylase and β-actin were
unchanged in the SNAP-25 knockdown cells and in the
control transfected cells. The knockdown of SNAP-25 was
also very specific to rat SNAP-25 in that human and
zebrafish SNAP-25 could be expressed from cDNA plas-
mids in the SNAP-25 knockdown cells, but expression of
rat SNAP-25 from a cDNA plasmid was silenced (Figure
2C, lanes 4–6). Human and zebrafish SNAP-25 cDNA dif-
fer from the rat SNAP-25 target site by only 2 or 4 of the
19 nucleotides, but these differences were sufficient to
make human and zebrafish SNAP-25 mRNA resistant to
RNA interference triggered by the rat SNAP-25 shRNA.
This resistance allowed the human SNAP-25 isoform to be
used in rescue experiments described below [21,22]. Note
that the less intense SNAP-25 bands in lanes 4 and 6 of
Figure 2C do not reflect partial knockdown of human and
zebrafish SNAP-25. The SNAP-25 in lanes 4 and 6 is
derived solely from the ~15–20% of cells that are tran-
siently transfected with the human and zebrafish SNAP-
25 cDNA plasmids. The fact that 15–20% of the cells con-
tain ~50% of the normal SNAP-25 means that human and
zebrafish SNAP-25 is actually over-expressed (2–3 times
normal) in the transiently transfected SNAP-25 knock-
down cells. The more intense bands in the "Control Trans-
fected" cell (Figure 2C, lanes 7–9) represents normal
levels of SNAP-25 in all the cells plus over-expression of
SNAP-25 in the 15–20% of the cells transiently trans-
fected with the SNAP-25 expression plasmids. Densitom-
etry of the immunoblot indicated that the amount of
SNAP-25 in lanes 7–9 is approximately equal to the sum
of SNAP-25 in untransfected PC12 cells (lane 1) plus the
human or zebrafish SNAP-25 in lanes 4 and 6.
Under some conditions shRNAs and siRNAs can lead to
repression of translation rather than degradation of spe-
cific mRNAs by RNA interference [23]. The knockdown of
SNAP-25 in the cell lines described here is presumably
due to RNA interference because levels of SNAP-25 mRNA
(as assessed by RT-PCR) were found to be reduced in the
SNAP-25 knockdown cells (Figure 2D). When a larger
fraction of the reverse transcriptase reaction was used for
PCR, some PCR product was obtained indicating that
SNAP-25 mRNA levels are reduced but not totally elimi-
nated. SNAP-25 mRNA levels could be quantified by real-
time quantitative RT-PCR. However, knowing the extent
of degradation of SNAP-25 mRNA would not enhance the
utility of the SNAP-25 knockdown cell line, so this option
was not pursued.
Amperometry experiments were carried out to determine
whether knockdown of SNAP-25 affected catecholamine
secretion from PC12 cells. The amperometric current
recorded from a control transfected PC12 cell is shown in
Figure 3A. The trace shows that application of high-K+ for
2.5 minutes elicited a large number of amperometric
events. Averaging every individual amperometric event
during the high-K+  stimulation produced the average
amperometric event shown to the right (Figure 3A). Figure
3B shows similar data from a SNAP-25 knockdown PC12
cell. It too had many events, but on average fewer than did
control transfected cells. Although the average ampero-
metric event for these cells (Figure 3B, right) tended to be
smaller, the difference was not significant and the amount
of neurotransmitter released by both types of cells was vir-
tually identical (Figure 3C; n = 18 control transfected cells;BMC Neuroscience 2006, 7:9 http://www.biomedcentral.com/1471-2202/7/9
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n = 18 knockdown cells). SNAP-25 knockdown cells pro-
duced an average of 29 release events per high-K+ stimula-
tion, while control transfected cells produced an average
of 79 release events (Fig 3D). Knockdown of SNAP-25 led
to a 63% reduction in the total number of exocytotic
events observed. Because the area under the curve of
amperometric events in control transfected and knock-
down cells were virtually identical, this data suggests that
Catecholamine secretion is reduced in SNAP-25 knockdown PC12 cells Figure 3
Catecholamine secretion is reduced in SNAP-25 knockdown PC12 cells. Representative amperometric traces are 
shown from a control cell stably transfected with pG418-shRNA lacking an shRNA insert (empty vector) (A) and from a 
SNAP-25 knockdown cell prior to and during a 2.5 min stimulation with 60 mM KCl (B). To the right of each of the traces is an 
averaged amperometric event shown on an expanded time scale. C) When compared to empty vector controls (n = 18) the 
silencing of SNAP-25 in PC12 cells (n = 18) did not alter the number of norepinephrine molecules per release event. D) Silenc-
ing of SNAP-25 resulted in a 63% reduction in the total number of exocytotic events produced following stimulation. Control 
transfected cells and SNAP-25 knockdown cells produced a mean ± SEM of 79 ± 17 events and 29 ± 10 events, respectively. *p 
< 0.03 (Student's t-test). E) Transient transfection with a human SNAP-25 expression plasmid rescued the deficit in catecho-
lamine secretion in the SNAP-25 knockdown cells. *p < 0.03 (Student's t-test).
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SNAP-25 knockdown cells released ~37% of the neuro-
transmitter of that released by control transfected cells.
Transient over-expression of human SNAP-25 in the
SNAP-25 knockdown cells rescued the deficit in neuro-
transmitter release (Figure 3E). In this experiment, trans-
fected cells were identified by co-expression of EGFP.
Human SNAP-25 increased neurotransmitter release by
~3.7 fold.
Discussion
We have used RNA interference to generate a PC12 cell
line with ~5% of normal levels of the SNARE protein
SNAP-25, and we have begun to characterize what effects
the lack of SNAP-25 has on catecholamine secretion from
these cells. RNA interference is most commonly done on
a transient basis, but the use of plasmid or viral vectors
designed to express shRNAs allows the generation of sta-
ble cells lines with permanently reduced levels of a spe-
cific protein [15,24,25]. Stable expression of shRNAs also
allows effective suppression even of proteins that turn
over slowly. Stable cell lines can be characterized as to the
specificity and extent of knockdown of the targeted gene
product and then used without the need to assess or make
assumptions about the effectiveness of knockdown in
each transient transfection. The generation of stable cell
lines also affords the possibility of obtaining cells with
different levels of knockdown [26,27]. Although the
results reported here focus solely on the PC12 cell line
with barely detectable levels of SNAP-25, several other cell
lines with varying levels of SNAP-25 were generated in the
course of this work. These may be useful for investigating
the effects of varying levels of SNAP-25 on secretion.
The ability to rescue or reverse an RNA interference-
induced effect using a version of the targeted gene that is
not recognized by the siRNA or shRNA is considered to be
one of the best controls for specificity in any RNA interfer-
ence experiment [9,21]. In the present work we have
shown that the knockdown of endogenous rat SNAP-25 in
PC12 cells is specific in that human and zebrafish SNAP-
25 can be expressed in the SNAP-25 knockdown cells, and
transient expression of human SNAP-25 rescued the defi-
cits in catecholamine secretion observed in the SNAP-25
knockdown cells.
The role of SNAP-25 in exocytosis previously has been
studied in SNAP-25 knockout mice [3,4], in bovine chro-
maffin cells treated with botulinum toxins A or E to spe-
cifically cleave SNAP-25 [6,7], and in a synaptosomal
membrane preparation treated with antibodies against
SNAP-25 [5]. The antibody treatment reduced Ca2+-
dependent glutamate release by 60–70%, but it was not
clear whether the residual secretion was due to SNAP-25
that had escaped inactivation by the antibody or due to a
SNAP-25-independent mechanism. Cleavage of bovine
chromaffin cell SNAP-25 by botulinum toxin E almost
completely inhibited the secretion of catecholamines elic-
ited by intracellular uncaging of chelated Ca2+ [6]. In con-
trast botulinum toxin A only partially inhibited
catecholamine secretion [6], and this inhibition could be
partially overcome by higher intracellular levels of Ca2+
[7]. These studies provided strong evidence for a crucial
role of SNAP-25 in exocytosis, but neither antibodies not
botulinum toxins can produce an experimental prepara-
tion that truly lacks SNAP-25 as do homozygous SNAP-25
knockout mice [3]. In neurons cultured from embryonic
SNAP-25 knockout mice, depolarization-induced exocy-
tosis was not detectable while spontaneous neurotrans-
mission persisted. In chromaffin cells isolated from
embryonic SNAP-25 knockout mice, the fast burst of cat-
echolamine secretion in response to uncaging of chelated
Ca2+ was abolished while a more prolonged elevation of
intracellular Ca2+ obtained by infusion of 10 µM Ca2+
through a patch pipet reduced the number of amperomet-
ric spikes of catecholamine secretion in SNAP-25 knock-
out cells to about 33% of that in control cells [4]. This
reduction in sustained secretion is very similar to the
reduction in number of amperometric spikes measured in
our SNAP-25 knockdown PC12 cells (37% of control).
The slow kinetics of bath application of high K+ did not
allow us to evaluate the effect of SNAP-25 knockdown on
the burst components of exocytosis. Also similar to the
findings in this study, the kinetic parameters of the amper-
ometric spikes in SNAP-25 knockout chromaffin cells
were similar to those found in wild-type cells [4].
There has been one other report of SNAP-25 knockdown
by RNA interference [28]. In this study a plasmid express-
ing a SNAP-25 shRNA was used to transiently knockdown
SNAP-25 in cultured hippocampal neurons, but neuro-
transmitter release from these neurons was not examined.
The catecholamine secretion that persists in the SNAP-25
knockdown cells may be mediated by SNAP-25 homologs
such as SNAP-23. We did not observe any compensatory
increase in SNAP-23 levels in the SNAP-25 knockdown
cells, but the possible role of SNAP-23 or other SNARE
proteins could be investigated by generating cell lines
expressing two or more shRNAs targeting distinct pro-
teins. It has been shown that it is possible to use RNA
interference to knockdown more than one gene product
[29,30], and we have preliminary evidence that PC12 cells
stably transfected with at least two plasmids can be gener-
ated at a reasonable frequency. The ability to specifically
reduce levels of SNAP-25 and other constituent proteins
of the SNARE complex in PC12 cells will provide a unique
opportunity to study the roles of each of these proteins in
exocytosis.BMC Neuroscience 2006, 7:9 http://www.biomedcentral.com/1471-2202/7/9
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Conclusion
A PC12 cell line stably transfected with a plasmid express-
ing an shRNA targeting SNAP-25 has been established.
This SNAP-25 knockdown cell line has ~5% of normal
levels of SNAP-25, but normal levels of other synaptic
proteins. Catecholamine secretion elicited by depolariza-
tion of the SNAP-25 knockdown cells was reduced to 37%
of control, but was restored by transient expression of
human SNAP-25. The combination of RNAi and subse-
quent rescue with a gene from a different species in a cell
line provides a viable method for the study of synaptic
proteins that would otherwise be lethal in animals.
Methods
Plasmid construction
When this project was started, plasmids for the expression
of shRNAs had been described in the literature [12-16,31],
but were not yet commercially available. In addition none
of the described plasmids contained drug-resistance genes
allowing selection of stably transfected cells. Therefore, an
shRNA expression plasmid containing the mouse U6 RNA
polymerase III promoter and a selection cassette to confer
resistance to G418 was constructed. The promoter from
the mouse U6 RNA polymerase III gene was cloned by
PCR using mouse genomic DNA as the template and
primers designed from the published sequence of the
mouse U6 gene [GenBank:X06980]. The PCR primers
were also designed to incorporate Hind III, Bpi I and Bam
HI restriction sites on the ends of the PCR product. The U6
promoter PCR product was digested with Hind III and
BamHI and ligated into pBSII cut with these same
enzymes. The U6 promoter region was sequenced to
ensure no mistakes had been introduced during the PCR
cloning. The G418-resistance cassette from pPNT [32] was
then sublconed into the U6-pBSII plasmid to yield
pG418shRNA (Figure 1A).
A target region for silencing rat SNAP-25 was selected
from a region of the cDNA that is common to both SNAP-
25a and SNAP-25b so that both isoforms would be tar-
geted. The selected site (GTTGGATGAGCAAGGCGAA, bp
355–373 of [GenBank:NM_030991]) conformed to many
of the guidelines for effective shRNAs: 52% G+C content;
no regions with >9 G/C; no runs of >3 of any nucleotide;
G on the 5'-end; A on the 3'-end; located >100 nucleotides
from the start codon [19]; but did not fully meet the more
advanced criteria for effective shRNAs that are based on
thermodynamic properties of the target sequence [17,18].
The loop sequence chosen for the shRNA (TTCAAGAGA)
was suggested by Brummelkamp et al. [15]. Complemen-
tary deoxyoligonucleotides containing the shRNA target
sequence, the loop sequence, the reverse complement of
the target sequence, an RNA polymerase III termination
sequence, and restriction-site compatible overhangs were
designed as shown in Figure 1B and were purchased from
IDT (Coralville, IA). The deoxyoligonucleotides were
annealed and ligated into pG418shRNA to yield
pG418shRNA-SNAP-25. The predicted shRNA expressed
by this plasmid is shown in Fig 1C.
Transfection and selection of stably transfected PC12 cells
PC12 cells (1.25 × 106) [33] were transfected with 4 µg of
either pG418shRNA-SNAP-25 or pG418shRNA using
Lipofectamine 2000. One day after transfection the cells
were replated at a lower density and selected with 100 µg/
ml G418 for 26 days until discrete colonies were formed.
PC12 cells grow slowly with a doubling time of about 3
days, hence the relatively long time before G418 resistant
colonies were formed. Individual colonies were isolated,
grown up and tested by PCR for the incorporation of the
plasmid into genomic DNA.
Immunoblotting
Levels of SNAP-25, SNAP-23, syntaxin 1A, synaptotagmin
I, tyrosine hydroxylase and β-actin in the cell lines were
assessed by immunoblotting with the following antibod-
ies: SNAP-25 (ANR-001, Alomone), SNAP-23 (DS-19;
Sigma), syntaxin 1A (#573831, Calbiochem), synaptotag-
min I (mAb48; Developmental Systems Hybridoma Bank,
University of Iowa), tyrosine hydroxylase (#657010, Cal-
biochem), β-actin (JLA20; Developmental Systems Hybri-
doma Bank, University of Iowa), and horseradish
peroxidase-labeled anti-mouse or anti-rabbit IgG (Jackson
ImmunoResearch). ECL Advance reagents (Amersham/
GE Healthcare) were used for detection of the horseradish
peroxidase-labeled secondary antibodies.
RT-PCR
Total RNA was isolated using Trizol (Invitrogen) and the
RNA was reverse-transcribed using Superscript II (Invitro-
gen) and random hexamers. PCR was carried out using
first-strand cDNA obtained by reverse transcription and
primers that span exon junctions of the rat SNAP-25 gene
(Exons 3–4: CGAAGAGAGTAAAGATGCTGGC; bp 316–
338 of rat SNAP-25 [GenBank:NM_030991]; and Exons
7–8 GTTTTGTTGGAGTCAGCCTTCT; reverse comple-
ment of bp 755–777). The use of primers that span exon
junctions assures that the PCR product is amplified only
from cDNA and not genomic DNA.
Expression of SNAP-25 Isoforms resistant to RNA 
interference
Plasmids for expression of rat, human and zebrafish
SNAP-25 were obtained from ATCC (IMAGE Clone IDs:
7314318, 3867544, and 6996354) and transfected into
the SNAP-25 knockdown and the control transfected cells
using Lipofectamine 2000. SNAP-25 levels were assessed
by immunoblotting. Human, rat and zebrafish SNAP-25
were all recognized by the anti-SNAP-25 antibody. In
experiments designed to assess whether human SNAP-25BMC Neuroscience 2006, 7:9 http://www.biomedcentral.com/1471-2202/7/9
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could rescue the deficit in catecholamine secretion,
pEGFP-N1 was co-transfected with the human SNAP-25
IMAGE clone to allow identification of transiently trans-
fected cells.
Catecholamine secretion and amperometry
Carbon fiber electrodes were fabricated and prepared for
recording as previously described [34]. On the day of the
experiment all cells were loaded with catecholamine
transmitter by 2–4 hr incubations in culture media con-
taining 2 mM norepinephrine prior to recording. The elec-
trode was pressed gently against the cell during the
recording for the highest collection efficiency possible
[35,36]. The electrode was held at + 700 mV vs ground
using an NPI VA-10 amplifier to oxidize catecholamine
transmitter. The amperometric signal was low-pass fil-
tered at 2 kHz (8-pole Bessel; Warner Instruments, Ham-
den, CT, USA). A 16-bit analog-to-digital converter
(National Instruments Corp., Austin, TX) was interfaced
with custom data acquisition software. The amperometric
signal was acquired at 10 kHz and stored on a personal
computer. Amperometric spike features and kinetic
parameters were analyzed using a series of macros written
in Igor Pro (Wavemetrics Inc.) kindly supplied by Dr.
Eugene Mosharov (Columbia University). The detection
threshold for an event was set at 4 – 5 times the baseline
root mean squared noise, and the spikes were automati-
cally detected. Amperometric data was obtained from 66
cells.
Recording solutions and stimulation protocol
Recordings were made from adherent cells that were
under constant perfusion (flow rate of 1.0 ml/min, and a
chamber volume of ~150 µl). The wash solution had the
following standard composition: 145 mM NaCl, 2.0 mM
KCl, 10 mM HEPES, 2 mM CaCl2 and 1.0 mM MgCl2.
High potassium (high-K+) solutions contained 82 mM
NaCl, 60 mM KCl, 10 mM HEPES, 2 mM CaCl2 and 1.0
mM MgCl2. The solutions were adjusted to a final pH of
7.3 and an osmolarity of 300 ± 3 mOsm/kg. All experi-
ments were performed at ambient temperature (24° ±
2°C). Cells were initially perfused with wash solution for
at least 1 min prior to being stimulated with High-K+ solu-
tion for 2.5 mins. Cells were subjected to only a single
stimulation.
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